Clinical trials
Phase 4 Carcinoma, Non-Small-Cell Lung trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 10 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Betta Pharmaceuticals Co., Ltd. | 4 |
| Hoffmann-La Roche | 3 |
| Simcere Pharmaceutical Co., Ltd | 3 |
| Peking University First Hospital | 2 |
| Pfizer | 2 |
| Shanghai Pulmonary Hospital, Shanghai, China | 2 |
| Sun Yat-sen University | 2 |
| Fujian Cancer Hospital | 1 |
| Guangdong Association of Clinical Trials | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 34 |
| Lung Neoplasms | 3 |
| Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Brain Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Bronchial Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Bronchogenic | 1 |
| Delirium | 1 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.